IP Library Granted Patent US 11,950,964
Granted Patent B2
US 11,950,964 · App. 16/276,896 · Granted Apr 9, 2024

Medical device with mitigation for tissue perforation

Inventors: Nikhil M. Murdeshwar (Maple Grove, MN); Kester J. Batchelor (Mound, MN)
Assignee: Gyrus ACMI, Inc.
A61B90/06A61B18/00A61B34/20A61B2017/00084A61B2018/00559A61B2018/00577A61B2034/2046A61B2090/065A61B2090/08021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,950,964
App. No.
16/276,896
Granted
Apr 9, 2024
Kind
B2
Abstract

A medical device that includes an introducer and a sensor. The introducer is configured to be inserted into a body cavity through a constricted channel. The introducer includes a predetermined section. The sensor is configured to generate a signal while the predetermined section of the introducer is located inside of the body cavity.

Claims (50)

1. A medical device comprising:

an introducer configured to be inserted into a uterine cavity through a cervical canal which is narrower than the uterine cavity, the introducer extending from a proximal end to a distal end and comprising a treatment device and a predetermined section at the distal end, the distal end of the introducer being contoured or tapered to assist in inserting the introducer through the cervical canal and into the uterine cavity while preventing perforation of surrounding tissue, the treatment device configured to activate a treatment modality at the distal end of the introducer;

a sensor located at the predetermined section; and

a controller;

wherein, in use:

the sensor generates a first status signal while the predetermined section of the introducer is located inside of the cervical canal and the sensor is in intimate contact with tissue of the cervical canal;

the sensor generates a second status signal while the predetermined section of the introducer is located inside of an area that is wider than the cervical canal and the sensor is free of the intimate contact with the tissue;

the controller generates a signal which indicates the sensor is free of the intimate contact with the tissue and the predetermined section of the introducer is located in the uterine cavity when the second status signal is preceded by the first status signal;

the treatment device activates the treatment modality at the distal end of the introducer after determining that the predetermined section of the introducer is located in the uterine cavity; and

the controller does not generate the signal which indicates the sensor is free of the intimate contact with the tissue and the predetermined section of the introducer is located in the uterine cavity when the second status signal is not preceded by the first status signal.

2. The medical device according to claim 1 , wherein while the predetermined section of the introducer is located inside of the cervical canal and the sensor is in intimate contact with the tissue of the cervical canal, contact with the tissue applies a force onto the sensor to move a portion of the sensor towards an outer surface of the introducer and into a compressed position, and

wherein the sensor is configured to correlate movement of the sensor towards the outer surface of the introducer or the sensor being in the compressed position as the predetermined section of the introducer being located inside of the cervical canal.

3. The medical device according to claim 2 , wherein while the predetermined section of the introducer is located inside of the uterine cavity, the sensor is free of the intimate contact with the tissue and the sensor moves away from the outer surface of the introducer into an elevated position,

wherein the sensor is configured to correlate movement of the sensor away from the outer surface of the introducer or the sensor being in the elevated position as the predetermined section of the introducer being located inside of the uterine cavity.

4. The medical device according to claim 1 , wherein the sensor rotates relative to the predetermined section.

5. The medical device according to claim 1 , wherein the sensor displaces relative to the predetermined section.

6. The medical device according to claim 1 , wherein the sensor comprises a distally-located contact sensor and a proximally-located contact sensor, and wherein the sensor is configured to correlate a lack of intimate contact of tissue on the distally-located contact sensor and intimate contact of tissue on the proximally-located contact sensor as the predetermined section of the introducer being at least partially located inside of the cervical canal.

7. The medical device according to claim 1 , wherein the sensor comprises a distally-located contact sensor and a proximally-located contact sensor, and wherein the sensor is configured to correlate a lack of intimate contact of tissue on the distally-located contact sensor and a lack of intimate contact of tissue on the proximally-located contact sensor as the predetermined section of the introducer being located inside of the uterine cavity.

8. The medical device according to claim 1 , wherein the sensor comprises a distally-located contact sensor and a proximally-located contact sensor, and wherein the sensor is configured to correlate intimate contact of tissue on the distally-located contact sensor and intimate contact of tissue on the proximally-located contact sensor as the predetermined section of the introducer being located inside of the cervical canal.

9. The medical device according to claim 1 , wherein the sensor comprises a distally-located contact sensor and a proximally-located contact sensor, and wherein the sensor is configured to correlate intimate contact with tissue on the distally-located contact sensor and lack of intimate contact with tissue on the proximally-located contact sensor as the predetermined section of the introducer being partially located inside of the cervical canal.

10. The medical device according to claim 1 , wherein, in use:

the controller generates a second signal which indicates the predetermined section of the introducer is located in the cervical canal when the sensor generates the first status signal.

11. The medical device according to claim 1 , wherein the first status signal is indicative of the sensor being in a compressed position.

12. The medical device according to claim 11 , wherein the second status signal is indicative of the sensor being in an uncompressed position.

13. The medical device according to claim 1 , wherein the first status signal is indicative of physical contact between the sensor and the cervical canal.

14. The medical device according to claim 13 , wherein the second status signal is indicative of the absence of contact between the sensor and the cervical canal.

15. A medical device comprising:

an introducer configured to be inserted into a uterine cavity through a cervical canal which is narrower than the uterine cavity, the introducer including a treatment device configured to activate a treatment modality at a distal end of the introducer;

a sensor at the distal end of the introducer; and

a controller;

wherein the introducer is configured to place the sensor in intimate contact with tissue during insertion of the introducer into the cervical canal and to remove the sensor from the intimate contact with tissue after the introducer is inserted into the uterine cavity;

wherein, in use:

the sensor provides a first status signal when the sensor is in intimate contact with the tissue inside of the cervical canal and provides a second status signal when the sensor is free of the intimate contact with the tissue;

the controller generates a signal which indicates the distal end of the introducer is located in the uterine cavity when the second status signal is preceded by the first status signal;

the treatment device activates the treatment modality at the distal end of the introducer after determining that the distal end of the introducer is located in the uterine cavity; and

the controller does not generate the signal which indicates the distal end of the introducer is located in the uterine cavity when the second status signal is not preceded by the first status signal.

16. The medical device according to claim 15 , wherein the sensor comprises a proximally-located contact sensor and a distally-located contact sensor, and wherein the sensor is configured to provide the first status signal after the distally-located contact sensor is in the intimate contact with the tissue and the proximally-located contact sensor is in the intimate contact with the tissue.

17. The medical device according to claim 15 , wherein the sensor comprises a proximally-located contact sensor and a distally-located contact sensor, and wherein the sensor is configured to provide the second status signal after the distally-located contact sensor is free of the intimate contact with the tissue and the proximally-located contact sensor is free of the intimate contact with the tissue.

18. The medical device according to claim 15 , wherein the first status signal is indicative of the sensor being in a compressed position.

19. The medical device according to claim 18 , wherein the second status signal is indicative of the sensor being in an uncompressed position.

20. A medical device comprising:

an introducer configured to be inserted into a uterine cavity through a cervical canal which is narrower than the uterine cavity, the introducer extending from a proximal end to a distal end and comprising a distal section at the distal end, the distal end of the introducer being contoured or tapered to assist in inserting the introducer through the cervical canal and into the uterine cavity while preventing perforation of surrounding tissue, the introducer further comprising a treatment device configured to activate a treatment modality at the distal end of the introducer;

a sensor located at the distal section; and

a controller;

wherein, in use:

the sensor generates a first status signal while the distal section of the introducer is located inside of the cervical canal and the sensor is in intimate contact with tissue;

the sensor generates a second status signal while the distal section of the introducer is located inside of an area that is wider than the cervical canal and the sensor is free of the intimate contact with the tissue;

the controller generates a signal which indicates the distal section of the introducer is located in the uterine cavity when the second status signal is preceded by the first status signal;

the treatment device activates the treatment modality at the distal end of the introducer after determining that the distal section of the introducer is located in the uterine cavity; and

the controller does not generate the signal which indicates the distal section of the introducer is located in the uterine cavity when the second status signal is not preceded by the first status signal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2019
From: MURDESHWAR, NIKHIL M.; BATCHELOR, KESTER J.
To: GYRUS ACMI, INC., D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 048346/0544 →
Continuity (1)
Related Publication 20200261178A1 · Aug 20, 2020